Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Apr 2012 07:00

RNS Number : 1659B
Byotrol PLC
12 April 2012
 



 

 12 April 2012

Byotrol plc

Trading Update

 

 

Byotrol plc ('Byotrol' or the "Company"), the developer of anti microbial hygiene technologies, is pleased to provide a trading update for the year to 31 March 2012, in advance of its annual results which are scheduled to be announced in June.

 

Trading Performance

 

Byotrol reports that it has seen growth in revenue in the second half of the year and results are expected to be in line with market expectations. Revenue for the year is anticipated to be approximately £1.96m (2011: £1.93m) and the cash balance at 31 March 2012 was £1.6m which is higher than previously anticipated. The Company has also successfully completed the technical milestones required by its Fortune 150 partner.

 

Operational Highlights

 

The year to 31 March 2012 saw the market launch of Rentokil Initial plc's UltraProtect™ range of hand and surface sanitising products, powered by Byotrol, under the contract announced in July 2011. Plans are underway to introduce UltraProtect™ across Europe in the remainder of 2012. It is expected that the new revolutionary sanitiser will soon be available in more than ten countries, and it has already launched in the UK, France and Germany. The Company expects further revenue growth in the coming year from this agreement.

 

The Company also reports that its technology has been adopted across the entire fleet of cruise line operator Holland America as the anti-microbial control choice for high contact touch areas.

 

Byotrol has continued to receive industry accolades for its revolutionary product as evidenced by its recent receipt of the prestigious 'Chemicals North-West 2012 Innovation Award' and shortlistings for the upcoming Chemicals UK equivalent and British Sandwich Association technical excellence award.

 

Byotrol Consumer Products Limited continues to work under a Joint Development Agreement with its Fortune 150 partner company having successfully completed the technical milestones required. The two companies are currently completing consumer research and commercial analysis with the aim of a decision on a full commercial agreement in the second half of 2012.

 

In addition, the Company is now benefitting from its technology being used in products sold by PZ Cussons, the Mayborn Group (owners of the Tommee Tippee brand), Boots and Tesco, among others. In particular, and via its relationship with Robert McBride Ltd, the Company has recently increased its presence in Tesco stores from one to three different trigger spray anti bacterial products.

 

 

Gary Millar, CEO of Byotrol, commenting said:

 

"Byotrol's new commercial strategy is already generating more repeatable, sustainable revenues with key strategic partners. The trading performance and tight cost control shows that the Company is moving in the right direction, and we look forward to further progress in the coming financial year."

 

 

Enquiries:

 

Byotrol plc

Gary Millar - Chief Executive

Richard Bell - Finance Director

 

finnCap

Geoff Nash/Christopher Raggett - Corporate Finance

Simon Starr - Corporate Broking

 

Winningtons

Tom Cooper/Paul Vann

01925 742 000

 

 

 

020 7220 0500

 

 

020 3176 4722

0797 122 1972

tom.cooper@winningtons.co.uk

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading microbial technology hygiene company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, microbacteria and algae.

 

The Byotrol product can be used as a standalone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQFLFFLZFLBBZ
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.